Bristol-Myers Squibb

New clot preventer works as well as warfarin with less bleeding
Reuters
Sun, 06/30/13 - 10:49 am
anti-clotting
Eliquis
Warfarin
Pfizer
Bristol-Myers Squibb
Eli Lilly Hopes To End Novo Nordisk's Stranglehold On The GLP-1 Market
Seeking Alpha
Fri, 06/28/13 - 10:13 am
Novo Nordisk
diabetes
Eli Lilly
GLP-1 agonist
AstraZeneca
Bristol-Myers Squibb
dulaglutide
Victoza
Is This What the Doctor Ordered for Eli Lilly?
Motley Fool
Thu, 06/27/13 - 08:55 pm
Eli Lilly
diabetes
dulaglutide
JNJ
Merck
Novo Nordisk
Bristol-Myers Squibb
Achillion May Be The Most Underrated Biotech Left
Seeking Alpha
Wed, 06/26/13 - 09:35 am
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Vertex Pharmaceuticals
Indenix
ACH-3102
ACH-1625
hepatitis C
Troubled AstraZeneca models a new industry R&D tie-up as setbacks mount
Fierce Biotech
Mon, 06/24/13 - 11:12 am
AstraZeneca
Pascal Soriot
R&D
Amgen
Bristol-Myers Squibb
New GSK diabetes drug works, but faces tough competition
Reuters
Mon, 06/24/13 - 10:28 am
GSK
diabetes
albiglutide
GLP-1 agonist
Victoza
Byetta
Bydureon
Novo Nordisk
Bristol-Myers Squibb
AstraZeneca
Roller Coaster Path To Approval For Eliquis Uncovered By FDA Documents
Forbes
Fri, 06/21/13 - 08:54 am
Eliquis
FDA
Pfizer
Bristol-Myers Squibb
anticoagulants
AstraZeneca, Bristol diabetes drug disappoints in key test
Reuters
Wed, 06/19/13 - 10:28 am
Bristol-Myers Squibb
AstraZeneca
diabetes
Onglyza
Where Is Biotechnology's Next 'Anti-PD-1'?
Seeking Alpha
Tue, 06/18/13 - 09:50 am
anti-PD-1 immunotherapy
Dendreon
Merck
Bristol-Myers Squibb
Baxter International
Yervoy
Provenge
lambrolizumab
MPDL3208A
BMS makes another emerging market move with new Simcere deal
Fierce Pharma
Mon, 06/17/13 - 02:57 pm
Bristol-Myers Squibb
Simcere
China
Bristol-Myers Squibb and Simcere Enter Partnership to Co-Develop and Co-Commercialize Orencia(R) SC (abatacept) in China
Yahoo
Fri, 06/14/13 - 10:27 am
Bristol-Myers Squibb
China
Simcere
Orencia
rheumatoid arthritis
Bristol-Myers, AstraZeneca to present 33 abstracts at ADA Scientific Sessions
Yahoo/Fly on the Wall
Fri, 06/14/13 - 10:26 am
diabetes
Bristol-Myers Squibb
AstraZeneca
Diabetes Drugs Under Scrutiny As FDA Considers Another Study
Pharmalot
Wed, 06/12/13 - 12:40 pm
FDA
diabetes
Merck
Januvia
Onglyza
Bristol-Myers Squibb
Byetta
AstraZeneca
Eli Lilly
Novo Nordisk
Victoza
Tradjenta
Boehringer Ingelheim
Former Bristol-Myers Exec Pleads Guilty To Insider Trading
Pharmalot
Tue, 06/11/13 - 09:15 am
insider trading
Bristol-Myers Squibb
Why Did Immunotherapy Pioneer NewLink Genetics Reach A 52-Week High?
Seeking Alpha
Mon, 06/10/13 - 12:23 pm
immunotherapy
NewLink Genetics
Roche
Genentech
Bristol-Myers Squibb
Merck
HyperAcute Lung
HyperAcute Pancreas
ASCO Stocks That Should Sizzle in the Future
Motley Fool
Mon, 06/10/13 - 10:12 am
ASCO
Merck
Clovis Oncology
Bristol-Myers Squibb
Old-School Pharma/Biotech Dividend Paying Comparison
Seeking Alpha
Thu, 06/6/13 - 11:46 am
dividends
Amgen
Bristol-Myers Squibb
Merck
Hisun-Pfizer Pharmaceuticals
Bristol-Myers Squibb: The Untold Story Of Led Zeppelin
Seeking Alpha
Thu, 06/6/13 - 10:07 am
Bristol-Myers Squibb
Eli Lilly
Merck
Pfizer
Forest Labs
2 Under-Covered Pharma Stocks With Yields Above 3%
Seeking Alpha
Wed, 06/5/13 - 11:34 am
Eisai
Bristol-Myers Squibb
Eli Lilly
AstraZeneca
Lonza
Bristol-Myers Squibb and AstraZeneca say FDA will speed up review of lipid disorder drug
Yahoo/AP
Wed, 06/5/13 - 10:05 am
FDA
Bristol-Myers Squibb
metreleptin
AstraZeneca

Pages